| Characteristic |
Training (n=82)
No. of patients (%) |
Testing (n=40)
No. of patients (%) |
P value |
| Age (Median, range) |
65(33-84) |
67(43-78) |
0.8198 |
| No. of pack/year(Median, range) |
64(0-162) |
60(0-114) |
0.629 |
| Gender |
|
|
0.8006 |
| Male |
54(65.8) |
28(70) |
|
| Female |
28(34.2) |
12(30) |
|
| Cancer type |
|
|
0.2211 |
| squamous |
38(46.3) |
24(60) |
|
| adenocarcinoma |
44(53.7) |
16(40) |
|
| Tumor stage |
|
|
0.6089 |
| Stage I |
37(45.6) |
22(55) |
|
| Stage II |
18(22.2) |
8(20) |
|
| Stage III&VI |
26(32.1) |
10(25) |
|
| Unknown |
01(-) |
0(-) |
|
| History |
|
|
0.7635 |
| <15 years |
51(62.2) |
23(57.5) |
|
| »15 years |
31(47.8) |
17(42.5) |
|
|